Károly Szuhai

13.1k citations

211 papers · 8.2k indexed · h-index 52

Molecular Biology top 2%
Pulmonary and Respiratory Medicine top 0.5%
Oncology top 1%
Rheumatology top 0.5%
Genetics top 1%

Co-authors: Pancras C.W. Hogendoorn Judith V.M.G. Bovée Hans J. Tanke Daniëlle de Jong Jeroen Knijnenburg Carla Rosenberg Anne‐Marie Cleton-Jansen René H. Medema
Topics: Sarcoma Diagnosis and Treatment (76 papers)Bone Tumor Diagnosis and Treatments (49 papers)Genomic variations and chromosomal abnormalities (34 papers)
Cited by: Rheumatology Oral Surgery Pulmonary and Respiratory Medicine
Journals: Science Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: Netherlands United States Hungary

In The Last Decade

Károly Szuhai

209 papers receiving 8.1k citations

Peers

Countries citing papers authored by Károly Szuhai

Since Specialization

Citations

This map shows the geographic impact of Károly Szuhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Károly Szuhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Károly Szuhai more than expected).

Fields of papers citing papers by Károly Szuhai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Károly Szuhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Károly Szuhai. The network helps show where Károly Szuhai may publish in the future.

Co-authorship network of co-authors of Károly Szuhai

This figure shows the co-authorship network connecting the top 25 collaborators of Károly Szuhai. A scholar is included among the top collaborators of Károly Szuhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Károly Szuhai. Károly Szuhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NTRK amplification occurs frequently in pan-TRK immunopositive dedifferentiated liposarcomas 2025 ·Pathology & Oncology Research ·(unknown),G Papp,Károly Szuhai,Johanna Sápi,Katalin Dezső,Zoltàn Sápi	1
2	Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis 2023 ·JCI Insight ·(unknown),Marieke C. Barnhoorn,Hein W. Verspaget,(unknown),(unknown),Károly Szuhai,Lukas J.A.C. Hawinkels,Melissa van Pel,Jaap Jan Zwaginga,Dave L. Roelen,Frits Koning,María Fernanda Pascutti,Andrea E. van der Meulen‐de Jong	7
3	VISTA Expression on Cancer-Associated Endothelium Selectively Prevents T-cell Extravasation 2023 ·Cancer Immunology Research ·(unknown),Rouven Schoppmeyer,Marieke E. Ijsselsteijn,Antonios Somarakis,(unknown),Dennis F.G. Remst,(unknown),Cornelis A.M. van Bergen,Inge H. Briaire‐de Bruijn,(unknown),(unknown),Lukas J.A.C. Hawinkels,Roman I. Koning,Erik Bos,Judith V.M.G. Bovée,Noel F.C.C. de Miranda,Károly Szuhai,Jaap D. van Buul,J.H. Frederik Falkenburg,Mirjam H.M. Heemskerk	8
4	Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches 2022 ·Expert Opinion on Therapeutic Targets ·(unknown),L. van der Heijden,Kirsten van Langevelde,Károly Szuhai,Judith V.M.G. Bovée,Michiel A. J. van de Sande,Hans Gelderblom	17
5	Transformed Canine and Murine Mesenchymal Stem Cells as a Model for Sarcoma with Complex Genomics 2021 ·Cancers ·(unknown),Bas Verbruggen,Marianna A. Tryfonidou,Alwine B. Kruisselbrink,Hans J. Baelde,Karin E. de Visser,Károly Szuhai,Anne‐Marie Cleton-Jansen,Judith V.M.G. Bovée	7
6	Transcriptional progression during meiotic prophase I reveals sex-specific features and X chromosome dynamics in human fetal female germline 2021 ·PLoS Genetics ·Xueying Fan,Ioannis Moustakas,(unknown),(unknown),Geert Hamer,Leoni A. Louwé,Gonneke S. K. Pilgram,Károly Szuhai,Roberto Matorras,Cristina Eguizábal,Lucette van der Westerlaken,Hailiang Mei,Susana M. Chuva de Sousa Lopes	10
7	Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma 2020 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Megan Roche,Lin Zhao,Diana Whitaker‐Menezes,Tingting Zhan,Károly Szuhai,Judith V.M.G. Bovée,John A. Abraham,Wei Jiang,Ubaldo Martinez‐Outschoorn,(unknown)	24
8	Expanding the editable genome and CRISPR–Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking 2019 ·Nucleic Acids Research ·Xiaoyu Chen,(unknown),Qian Wang,Jin Liu,Josephine M. Janssen,Marcella Brescia,Milena Bellin,Károly Szuhai,(unknown),Richard L. Frock,Manuel A.F.V. Gonçalves	26
9	Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma 2018 ·Clinical Cancer Research ·David G.P. van IJzendoorn,Stefan Sleijfer,Hans Gelderblom,Ferry A.L.M. Eskens,Geert J.L.H. van Leenders,Károly Szuhai,Judith V.M.G. Bovée	35
10	Genomic analysis reveals recurrent deletion of JAK‐STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides 2018 ·Genes Chromosomes and Cancer ·(unknown),Davy Cats,Hailiang Mei,Károly Szuhai,Rein Willemze,Maarten H. Vermeer,Cornelis P. Tensen	50
11	High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma 2018 ·Journal of Molecular Diagnostics ·(unknown),(unknown),Lilit Atanesyan,(unknown),(unknown),(unknown),(unknown),András Matolcsy,Béla Kajtár,László Pajor,Károly Szuhai,Suvi Savola,Csaba Bödör,Donát Alpár	8
12	Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy 2016 ·Cancer Immunology Immunotherapy ·(unknown),Dagmar Berghuis,Károly Szuhai,Pancras C.W. Hogendoorn	14
13	Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT 2011 ·Oncogene ·Carlos E. de Andrea,Christianne M. A. Reijnders,Herman M. Kroon,Daniëlle de Jong,Pancras C.W. Hogendoorn,Károly Szuhai,Judith V.M.G. Bovée	51
14	No Haploinsufficiency but Loss of Heterozygosity for EXT in Multiple Osteochondromas 2010 ·American Journal Of Pathology ·Christianne M. A. Reijnders,Cathelijn J. F. Waaijer,Andrew Hamilton,Emilie P. Buddingh,P. D. S. Dijkstra,(unknown),Egbert Bakker,Károly Szuhai,Marcel Karperien,Pancras C.W. Hogendoorn,Sally E. Stringer,Judith V.M.G. Bovée	52
15	The NFATc2 Gene Is Involved in a Novel Cloned Translocation in a Ewing Sarcoma Variant That Couples Its Function in Immunology to Oncology 2009 ·Clinical Cancer Research ·Károly Szuhai,Marije IJszenga,Daniëlle de Jong,А. И. Карселадзе,Hans J. Tanke,Pancras C.W. Hogendoorn	154
16	Long–term culture of primary human lymphoblastic leukemia cells in the absence of serum or hematopoietic growth factors 2009 ·Experimental Hematology ·Bart Nijmeijer,Károly Szuhai,Henriëtte M. Goselink,Marianke L.J. van Schie,(unknown),Daniëlle de Jong,Erik W.A. Marijt,Oliver G. Ottmann,Roel Willemze,J.H. Frederik Falkenburg	52
17	Novel and Highly Recurrent Chromosomal Alterations in Sezary Syndrome 2008 ·Cancer Research ·Maarten H. Vermeer,Remco van Doorn,Remco Dijkman,Xin Mao,Sean Whittaker,Pieter C. van Voorst Vader,Marie‐Jeanne P. Gerritsen,Marie‐Louise Geerts,Sylke Gellrich,Ola Söderberg,Karl‐Johan Leuchowius,Ulf Landegren,Jacoba J. Out‐Luiting,Jeroen Knijnenburg,Marije IJszenga,Károly Szuhai,Rein Willemze,Cornelis P. Tensen	133
18	Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement 2008 ·Cancer Genetics and Cytogenetics ·(unknown),Károly Szuhai,J.H. Frederik Falkenburg,Marianke L.J. van Schie,Oliver G. Ottmann,Bart Nijmeijer	15
19	Molecular and clinical characterization of de novo and familial cases with microduplication 3q29: guidelines for copy number variation case reporting 2008 ·Cytogenetic and Genome Research ·Sharan Goobie,Jeroen Knijnenburg,David Fitzpatrick,Freddie H. Sharkey,Anath C. Lionel,Christian R. Marshall,(unknown),Mary Shago,Kelly K. Chong,Roberto Mendoza‐Londono,Nicolette S. den Hollander,Claudia Ruivenkamp,E.R. Maher,Hans J. Tanke,Károly Szuhai,Richard F. Wintle,Stephen W. Scherer	30
20	Array CGH and COBRA-FISH reveal recurrent genetic alterations in Sezary syndrome 2006 ·Journal of Investigative Dermatology ·(unknown),Remco Dijkman,(unknown),(unknown),Sean Whittaker,Sylke Gellrich,(unknown),Károly Szuhai,Rein Willemze,Cornelis P. Tensen	1

About Károly Szuhai

Károly Szuhai is a scholar working on Rheumatology, Oral Surgery and Pulmonary and Respiratory Medicine, having authored 211 papers that have together received 8.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (76 papers), Bone Tumor Diagnosis and Treatments (49 papers) and Genomic variations and chromosomal abnormalities (34 papers). The work is most often cited by research in Rheumatology (1.8k citations), Oral Surgery (723 citations) and Pulmonary and Respiratory Medicine (2.5k citations). Károly Szuhai has collaborated with scholars based in Netherlands, United States and Hungary. Frequent co-authors include Pancras C.W. Hogendoorn, Judith V.M.G. Bovée, Hans J. Tanke, Daniëlle de Jong, Jeroen Knijnenburg, Carla Rosenberg, Anne‐Marie Cleton-Jansen, René H. Medema, Geert J.P.L. Kops and Aniek Janssen. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact